Shinhung - Asset Resilience Ratio
Shinhung (004080) has an Asset Resilience Ratio of 4.17% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Check asset allocation strategy of Shinhung to assess the company's strategic physical and investment asset allocation.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2000–2024)
This chart shows how Shinhung's Asset Resilience Ratio has changed over time. See 004080 equity to assets ratio to measure how much of total assets are equity-financed.
Liquid Assets Composition Over Time
This chart breaks down Shinhung's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see Shinhung market cap and net worth.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | ₩0.00 | 0% |
| Short-term Investments | ₩6.40 Billion | 4.17% |
| Total Liquid Assets | ₩6.40 Billion | 4.17% |
Asset Resilience Insights
- Limited Liquidity: Shinhung maintains only 4.17% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
Shinhung Industry Peers by Asset Resilience Ratio
Compare Shinhung's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Medacta Group SA
SW:MOVE |
Medical Devices | 0.86% |
|
Double Medical Technology Inc
SHE:002901 |
Medical Devices | 12.59% |
|
Shenzhen New Industries Biomedical
SHE:300832 |
Medical Devices | 9.95% |
|
Jafron Biomedical Co Ltd
SHE:300529 |
Medical Devices | 39.15% |
|
Sinocare Inc
SHE:300298 |
Medical Devices | 3.53% |
|
Xiangyu Medical Co. Ltd. A
SHG:688626 |
Medical Devices | 1.53% |
|
INKON Life Technology Co Ltd
SHE:300143 |
Medical Devices | 5.73% |
|
HOB Biotech Group Corp Ltd
SHG:688656 |
Medical Devices | 2.62% |
Annual Asset Resilience Ratio for Shinhung (2000–2024)
The table below shows the annual Asset Resilience Ratio data for Shinhung.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2024-12-31 | 3.34% | ₩4.72 Billion ≈ $3.20 Million |
₩141.43 Billion ≈ $95.84 Million |
-1.39pp |
| 2023-12-31 | 4.73% | ₩6.63 Billion ≈ $4.50 Million |
₩140.33 Billion ≈ $95.10 Million |
+0.65pp |
| 2022-12-31 | 4.07% | ₩5.73 Billion ≈ $3.88 Million |
₩140.62 Billion ≈ $95.30 Million |
+3.26pp |
| 2021-12-31 | 0.81% | ₩1.12 Billion ≈ $760.35K |
₩138.61 Billion ≈ $93.94 Million |
-0.18pp |
| 2020-12-31 | 0.99% | ₩1.45 Billion ≈ $980.37K |
₩146.18 Billion ≈ $99.06 Million |
-0.96pp |
| 2019-12-31 | 1.95% | ₩2.86 Billion ≈ $1.94 Million |
₩146.70 Billion ≈ $99.42 Million |
-0.83pp |
| 2018-12-31 | 2.78% | ₩3.68 Billion ≈ $2.50 Million |
₩132.69 Billion ≈ $89.92 Million |
+1.45pp |
| 2017-12-31 | 1.33% | ₩1.74 Billion ≈ $1.18 Million |
₩131.26 Billion ≈ $88.95 Million |
-0.14pp |
| 2016-12-31 | 1.46% | ₩1.93 Billion ≈ $1.31 Million |
₩131.53 Billion ≈ $89.13 Million |
+0.04pp |
| 2015-12-31 | 1.43% | ₩1.95 Billion ≈ $1.32 Million |
₩136.99 Billion ≈ $92.83 Million |
+0.32pp |
| 2014-12-31 | 1.10% | ₩1.36 Billion ≈ $921.72K |
₩123.44 Billion ≈ $83.65 Million |
-1.14pp |
| 2013-12-31 | 2.25% | ₩2.90 Billion ≈ $1.97 Million |
₩129.29 Billion ≈ $87.62 Million |
+0.26pp |
| 2012-12-31 | 1.99% | ₩2.81 Billion ≈ $1.90 Million |
₩141.02 Billion ≈ $95.57 Million |
-0.37pp |
| 2011-12-31 | 2.36% | ₩3.35 Billion ≈ $2.27 Million |
₩142.05 Billion ≈ $96.26 Million |
+1.78pp |
| 2009-12-31 | 0.58% | ₩818.06 Million ≈ $554.39K |
₩140.73 Billion ≈ $95.37 Million |
-1.42pp |
| 2008-12-31 | 2.00% | ₩2.90 Billion ≈ $1.97 Million |
₩145.16 Billion ≈ $98.37 Million |
-0.86pp |
| 2007-12-31 | 2.86% | ₩3.91 Billion ≈ $2.65 Million |
₩136.59 Billion ≈ $92.57 Million |
-1.97pp |
| 2006-12-31 | 4.83% | ₩6.54 Billion ≈ $4.43 Million |
₩135.33 Billion ≈ $91.71 Million |
+3.32pp |
| 2005-12-31 | 1.51% | ₩1.79 Billion ≈ $1.21 Million |
₩118.39 Billion ≈ $80.23 Million |
-1.77pp |
| 2004-12-31 | 3.28% | ₩3.58 Billion ≈ $2.42 Million |
₩108.94 Billion ≈ $73.83 Million |
+2.56pp |
| 2003-12-31 | 0.72% | ₩800.00 Million ≈ $542.15K |
₩110.68 Billion ≈ $75.01 Million |
-3.41pp |
| 2002-12-31 | 4.14% | ₩4.27 Billion ≈ $2.89 Million |
₩103.29 Billion ≈ $70.00 Million |
-0.40pp |
| 2001-12-31 | 4.54% | ₩4.04 Billion ≈ $2.74 Million |
₩89.04 Billion ≈ $60.34 Million |
+1.33pp |
| 2000-12-31 | 3.21% | ₩2.86 Billion ≈ $1.94 Million |
₩89.31 Billion ≈ $60.53 Million |
-- |
About Shinhung
Shinhung Co., Ltd. manufactures, imports, and sells dental products and supplies in South Korea. Its products include implant systems; dental units and chairs; dental alloys, such as composition tables, crowns, and porcelain under the Goldenian brand name; prefabricates SS crowns; taurus, insert, and mobile cabinets; compressors and mixers; dental needles; dental porcelain powder and laboratory p… Read more